Enhanced activity and subcellular redistribution of myocardial hexokinase after acute myocardial infarction

International Journal of Cardiology

Volumn 149, Issue 1, 2011, Pages 74-79

  Yeih, Dong Feng ^a   Yeh, Hung I ^b   Lin, Lian Yu ^c   Tsay, Yeou Guang ^d   Chiang, Fu Tien ^c   Tseng, Chuen Den ^c   Tseng, Yung Zu ^c  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Heart failure; Metabolism; Mitochondrial translocation; Oxidative stress

Indexed keywords

ACONITATE HYDRATASE; HEXOKINASE; MALONALDEHYDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; CYTOSOL; DRESSLER SYNDROME; ELECTROCARDIOGRAM; ENZYME ACTIVITY; ENZYME LOCALIZATION; HEART INFARCTION; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; M MODE ECHOCARDIOGRAPHY; MALE; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RAT; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ANIMALS; CYTOSOL; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; ENERGY METABOLISM; ENZYME ACTIVATION; GLUCOSEPHOSPHATE DEHYDROGENASE; HEXOKINASE; MALE; MITOCHONDRIA; MYOCARDIAL INFARCTION; MYOCARDIUM; ORGAN SIZE; OXIDATIVE STRESS; PENTOSE PHOSPHATE PATHWAY; RATS; RATS, WISTAR;

EID: 79955943587     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.12.002     Document Type: Article

References (29)

1. Gheorghiade M, Bonow RO. Chronic heart failure in the United States: a manifestation of coronary artery disease. Circulation 1998;97:282-9. (Pubitemid 28067315)
2. Cleland JG, Khand A, Clark A. The heart failure epidemic: exactly how big is it? Eur Heart J 2001;22:623-6.
3. Giordano FJ. Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 2005;115:500-8. (Pubitemid 40322219)
4. Taegtmeyer H. Switching metabolic genes to build a better heart. Circulation 2002;106:2043-5. (Pubitemid 35192807)
5. Sawyer DB, Siwik DA, Xiao L, Pimentel DR, Singh K, Colucci WS. Role of oxidative stress in myocardial hypertrophy and failure. J Mol Cell Cardiol 2002;34:379-88. (Pubitemid 37163454)
6. von Harsdorf R, Li PF, Dietz R. Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis. Circulation 1999;99:2934-41. (Pubitemid 29258983)
7. Nian M, Lee P, Khaper N, Liu P. Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res 2004;94:1543-53. (Pubitemid 38856961)
8. Razeghi P, Young ME, Alcorn JL, Moravec CS, Frazier OH, Taegtmeyer H. Metabolic gene expression in fetal and failing human heart. Circulation 2001;104:2923-31. (Pubitemid 33139104)
9. Kalsi KK, Smolenski RT, Pritchard RD, Khaghani A, Seymour AM, Yacoub MH. Energetics and function of the failing human heart with dilated or hypertrophic cardiomyopathy. Eur J Clin Invest 1999;29:469-77. (Pubitemid 29271636)
10. Davila-Roman VG, Vedala G, Herrero P, et al. Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2002;40:271-7. (Pubitemid 34756287)
11. Kelleher JA, Chan PH, Chan TY, Gregory GA. Modification of hypoxia-induced injury in cultured rat astrocytes by high levels of glucose. Stroke 1993;24:855-63. (Pubitemid 23163560)
12. Allen CB, White CW. Glucose modulates cell death due to normobaric hyperoxia by maintaining cellular ATP. Am J Physiol 1998;274:L159-64.
13. Bryson JM, Coy PE, Gottlob K, Hay N, Robey RB. Increased hexokinase activity, of either ectopic or endogenous origin, protects renal epithelial cells against acute oxidant-induced cell death. J Biol Chem 2002;277:11,392-400.
14. Malhotra R, Brosius III FC. Glucose uptake and glycolysis reduce hypoxia-induced apoptosis in cultured neonatal rat cardiacmyocytes. J Biol Chem1999;274:12,567-75.
15. da-Silva WS, Gomez-Puyou A, de Gomez-Puyou MT, et al. Mitochondrial bound hexokinase activity as a preventive antioxidant defense: steady-state ADP formation as a regulatory mechanism of membrane potential and reactive oxygen species generation in mitochondria. J Biol Chem 2004;279:39,846-55.
16. Cadenas E, Davies KJ. Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med 2000;29:222-30.
17. Hayashidani S, Tsutsui H, Shiomi T, et al. Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation 2002;105(7):868-73. (Pubitemid 34174929)
18. Baines CP, Zhang J, Wang GW, et al. Mitochondrial PKCepsilon and MAPK form signaling modules in the murine heart: enhanced mitochondrial PKCepsilon-MAPK interactions and differential MAPK activation in PKCepsilon-induced cardioprotection. Circ Res 2002;90:390-7. (Pubitemid 34633907)
19. Baines CP, Wang L, Cohen MV, Downey JM. Myocardial protection by insulin is dependent on phospatidylinositol 3-kinase but not protein kinase C or KATP channels in the isolated rabbit heart. Basic Res Cardiol 1999;94:188-98. (Pubitemid 29329303)
20. Zuurbier CJ, Eerbeek O, Meijer AJ. Ischemic preconditioning, insulin, and morphine all cause hexokinase redistribution. Am J Physiol Heart Circ Physiol 2005;289:H496-9.
21. Tian WN, Braunstein LD, Pang J, et al. Importance of glucose-6-phosphate dehydrogenase activity for cell growth. J Biol Chem 1998;273:10,609-17.
22. Takemoto M,Node K, Nakagami H, et al. Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy. J Clin Invest 2001 Nov;108(10):1429-37. (Pubitemid 33091980)
23. Wang Y, Seburn K, Bechtel L, et al. Defective carbohydrate metabolism in mice homozygous for the tubby mutation. Physiol Genomics 2006;27:131-40. (Pubitemid 46702028)
24. Pastorino JG, Hoek JB. Hexokinase II: the integration of energy metabolism and control of apoptosis. Curr Med Chem 2003;10:1535-51. (Pubitemid 36896555)
25. Beutner G, Ruck A, Riede B, Welte W, Brdiczka D. Complexes between kinases, mitochondrial porin and adenylate translocator in rat brain resemble the permeability transition pore. FEBS Lett 1996;396:189-95. (Pubitemid 26377822)
26. Pastorino JG, Shulga N, Hoek JB. Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis. J Biol Chem 2002;277:7610-8. (Pubitemid 34953160)
27. Pastorino JG, Hoek JB, Shulga N. Activation of glycogen synthase kinase 3beta disrupts the binding of hexokinase II to mitochondria by phosphorylating voltage-dependent anion channel and potentiates chemotherapy-induced cytotoxicity. Cancer Res 2005;65:10,545-54.
28. Majewski N, Nogueira V, Bhaskar P, et al. Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. Mol Cell 2004;16:819-30. (Pubitemid 39586539)
29. Coats AJ. Ethical authorship and publishing. Int J Cardiol 2009;131:149-50.